• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多模式阶梯式治疗方法结合针刺和过氧化物酶体增殖物激活受体-α激动剂棕榈酸乙醇酰胺治疗多发性硬化症和中枢神经性疼痛患者。

Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain.

机构信息

Institute for Neuropathic Pain, Vespuccistraat 64-III, 1056 SN Amsterdam, The Netherlands.

出版信息

Acupunct Med. 2012 Mar;30(1):53-5. doi: 10.1136/acupmed-2011-010119. Epub 2012 Feb 1.

DOI:10.1136/acupmed-2011-010119
PMID:22301508
Abstract

Central neuropathic pain is a common debilitating symptom in patients with multiple sclerosis. Side effects of analgesics often limit reaching therapeutic dosages. In this case report, a 61-year-old woman with chronic central neuropathic pain due to multiple sclerosis is described. Acupuncture could only partly and temporarily reduce the pain. However, after adding the natural compound palmitoylethanolamide, a glial modulator and peroxisome proliferator-activated receptor-α agonist, pain reduction was more pronounced and the interval between acupuncture sessions could be increased. A multimodal stepped care approach is demonstrated, with acupuncture and palmitoylethanolamide both influencing non-neuronal cells, such as activated glial cells, which are key factors in the development and maintenance of neuropathic pain.

摘要

中枢神经性疼痛是多发性硬化症患者常见的致残症状。镇痛药的副作用常常限制了达到治疗剂量。在本病例报告中,描述了一位 61 岁的女性,她患有多发性硬化症引起的慢性中枢神经性疼痛。针灸只能部分且暂时缓解疼痛。然而,在添加天然化合物棕榈酸乙醇酰胺(一种神经胶质调节剂和过氧化物酶体增殖物激活受体-α激动剂)后,疼痛缓解更为明显,并且可以增加针灸治疗的间隔。展示了一种多模式阶梯式护理方法,针灸和棕榈酸乙醇酰胺都可以影响非神经元细胞,如激活的神经胶质细胞,这是非神经性疼痛发生和维持的关键因素。

相似文献

1
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain.多模式阶梯式治疗方法结合针刺和过氧化物酶体增殖物激活受体-α激动剂棕榈酸乙醇酰胺治疗多发性硬化症和中枢神经性疼痛患者。
Acupunct Med. 2012 Mar;30(1):53-5. doi: 10.1136/acupmed-2011-010119. Epub 2012 Feb 1.
2
Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.棕榈酰乙醇胺的中枢给药通过抑制背根神经节中的核因子κB核信号传导来减轻小鼠的痛觉过敏。
Eur J Pharmacol. 2009 Jun 24;613(1-3):54-9. doi: 10.1016/j.ejphar.2009.04.022. Epub 2009 Apr 20.
3
Neuropathic pain therapy: from bench to bedside.神经病理性疼痛治疗:从基础到临床。
Semin Neurol. 2012 Jul;32(3):264-8. doi: 10.1055/s-0032-1329204. Epub 2012 Nov 1.
4
Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.通过激活过氧化物酶体增殖物激活受体α实现快速广谱镇痛
J Pharmacol Exp Ther. 2006 Dec;319(3):1051-61. doi: 10.1124/jpet.106.111385. Epub 2006 Sep 22.
5
Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide.误诊的慢性盆腔痛:阴部神经痛对棕榈油酸乙醇酰胺的新用途有反应。
Pain Med. 2010 May;11(5):781-4. doi: 10.1111/j.1526-4637.2010.00823.x. Epub 2010 Mar 22.
6
Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.在多发性硬化症病毒模型中对内源性大麻素系统调节的研究揭示了棕榈酰乙醇胺的治疗作用。
Eur J Neurosci. 2008 Aug;28(4):633-41. doi: 10.1111/j.1460-9568.2008.06377.x. Epub 2008 Jul 24.
7
The search for the palmitoylethanolamide receptor.对棕榈酰乙醇胺受体的探寻。
Life Sci. 2005 Aug 19;77(14):1685-98. doi: 10.1016/j.lfs.2005.05.012.
8
Recommendations for neuropathic pain treatment.神经性疼痛治疗建议。
Acta Clin Croat. 2008 Sep;47(3):181-91.
9
Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice.急性脑室内给予内源性过氧化物酶体增殖物激活受体α激动剂棕榈酰乙醇胺,可调节角叉菜胶诱导的小鼠爪部水肿。
J Pharmacol Exp Ther. 2007 Sep;322(3):1137-43. doi: 10.1124/jpet.107.123265. Epub 2007 Jun 12.
10
[Therapeutic advances in pharmaceutical treatment of neuropathic pain].[神经性疼痛药物治疗的进展]
Rev Neurol (Paris). 2011 Dec;167(12):930-7. doi: 10.1016/j.neurol.2011.06.003. Epub 2011 Nov 17.

引用本文的文献

1
Effects of Palmitoylethanolamide on Neurodegenerative Diseases: A Review from Rodents to Humans.棕榈酰乙醇酰胺对神经退行性疾病的影响:从啮齿动物到人类的综述。
Biomolecules. 2022 May 5;12(5):667. doi: 10.3390/biom12050667.
2
Amorfrutins Relieve Neuropathic Pain through the PPAR/CCL2 Axis in CCI Rats.阿莫罗芬通过PPAR/CCL2轴缓解CCI大鼠的神经性疼痛。
PPAR Res. 2021 Jan 22;2021:8894752. doi: 10.1155/2021/8894752. eCollection 2021.
3
Tyrosine Kinase Receptors Axl and MerTK Mediate the Beneficial Effect of Electroacupuncture in a Cuprizone-Induced Demyelinating Model.
酪氨酸激酶受体Axl和MerTK介导电针在铜螯合剂诱导的脱髓鞘模型中的有益作用。
Evid Based Complement Alternat Med. 2020 Jul 4;2020:3205176. doi: 10.1155/2020/3205176. eCollection 2020.
4
Efficacy of a Combination of N-Palmitoylethanolamide, Beta-Caryophyllene, Carnosic Acid, and Myrrh Extract on Chronic Neuropathic Pain: A Preclinical Study.N-棕榈酰乙醇胺、β-石竹烯、鼠尾草酸和没药提取物联合应用对慢性神经性疼痛的疗效:一项临床前研究。
Front Pharmacol. 2019 Jun 27;10:711. doi: 10.3389/fphar.2019.00711. eCollection 2019.
5
Acupuncture-Analgesia-Mediated Alleviation of Central Sensitization.针刺镇痛介导的中枢敏化减轻
Evid Based Complement Alternat Med. 2019 Mar 7;2019:6173412. doi: 10.1155/2019/6173412. eCollection 2019.
6
PPAR-α acutely inhibits functional activity of ASICs in rat dorsal root ganglion neurons.过氧化物酶体增殖物激活受体-α急性抑制大鼠背根神经节神经元中酸敏感离子通道的功能活性。
Oncotarget. 2017 Oct 10;8(54):93051-93062. doi: 10.18632/oncotarget.21805. eCollection 2017 Nov 3.
7
Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats.棕榈酰乙醇胺对大鼠炎症性疼痛和神经性疼痛的影响。
Korean J Anesthesiol. 2017 Oct;70(5):561-566. doi: 10.4097/kjae.2017.70.5.561. Epub 2017 Jul 13.
8
Electroacupuncture Promotes Remyelination after Cuprizone Treatment by Enhancing Myelin Debris Clearance.电针通过增强髓鞘碎片清除促进曲吡酮治疗后的髓鞘再生。
Front Neurosci. 2017 Jan 10;10:613. doi: 10.3389/fnins.2016.00613. eCollection 2016.
9
Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy.用于治疗疼痛的棕榈酰乙醇胺:药代动力学、安全性和有效性。
Br J Clin Pharmacol. 2016 Oct;82(4):932-42. doi: 10.1111/bcp.13020. Epub 2016 Jun 29.
10
Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines?过氧化物酶体增殖物激活受体激动剂调节神经病理性疼痛:与趋化因子有关?
Front Cell Neurosci. 2014 Aug 20;8:238. doi: 10.3389/fncel.2014.00238. eCollection 2014.